Announcements
DTN-UK Launch New Webinar Series
Dr. Sufyan Hussain
Overview of hybrid closed loops - key concepts, options available and choosing the right system Wednesday 21st July 2021, 17.00 - 18.30 The DTN-UK are delighted to launch a three-part webinar series…
Diabetes UK announce new campaign: Diabetes is Serious
Dr. Dipesh Patel
Diabetes UK have announced the launch of their new campaign Diabetes is Serious, which aims to highlight the learnings and insights from their Diabetes Can't Wait report about the experiences…
Launch of NHS Digital Weight Management Programme
Professor Jonathan Valabhji
A new 12 week NHS Digital Weight Management Programme (DWMP) has formally launched today for people living with obesity and diabetes or hypertension. Referrals are via general practice. The slide…
Flash glucose monitoring use associated with a reduction in diabetes distress
Professor Thozhukat Sathyapalan
Users of the FreeStyle Libre system in the UK show improvements in glycaemic control and awareness of hypoglycaemia which are associated with improvement in diabetes-related distress, according to a…
Launch of the ABCD nationwide oral semaglutide audit at ADA 2021
Dr. Bob Ryder
Today at ADA 2021, ABCD is pleased to announce the launch of the ABCD nationwide oral semaglutide audit. As you will know, the clinical trials with semaglutide suggest that it may be more effective…
RD Lawrence Chair, Kings College London
King's College London are seeking applications for the prestigious RD Lawrence Chair. For further information please see the detailed advertisement.
Empagliflozin use is associated with reduction in alanine aminotransferase: insights from ABCD audit data practice
Dr. Thomas Crabtree
The ABCD Empagliflozin audit has provided valuable insights into empagliflozin use in UK based real-world practice. Additionally, data from the other SGLT2 audit programmes has demonstrated…
Empagliflozin use is associated with reduction in alanine aminotransferase: insights from ABCD audit data practice
Dr. Bob Ryder
The ABCD Empagliflozin audit has provided valuable insights into empagliflozin use in UK based real-world practice. Additionally, data from the other SGLT2 audit programmes has demonstrated…
Semaglutide use is associated with significant reductions in weight and HbA1c in the real-world: Results from the ABCD audit
Dr. Thomas Crabtree
We are pleased to be presenting our first analysis from the ABCD Semaglutide audit at the American Diabetes Association Scientific Session virtual session this weekend. Our real-world cohort was…
Semaglutide use is associated with significant reductions in weight and HbA1c in the real-world: Results from the ABCD audit
Dr. Bob Ryder
We are pleased to be presenting our first analysis from the ABCD Semaglutide audit at the American Diabetes Association Scientific Session virtual session this weekend. Our real-world cohort was…
RCP Webinar: Building your career as an SAS doctor
Dr. Robert Gregory
SAS doctors play a vital role in the delivery of NHS services but can sometimes be overlooked when it comes to career development and recognition. Join this webinar to hear from the chair of…
Quality in Care Diabetes 2021: Open for entries
Dr. Dipesh Patel
Entries and now open for Quality in Care Diabetes 2021, the prestigious UK & Ireland awards, which since 2011 have been recognising, rewarding and sharing initiatives that improve the quality of…
Dr. Bob Ryder, Consultant Diabetologist,
The ABCD audit programme was prominent at the recent EASD in Hamburg with four presentations. In particular, the presentation by Prof Hugh Jones of the ABCD testosterone in men with type 2…
